RxDoctor Payments Data

Jerry Williams

Family · Holly Springs, MSNPI 1073035168

Payments from drug & device makers

$823in general payments, 2019–2025

Across 45 payments — averaging $18.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$277
  • Boehringer Ingelheim$110
  • AbbVie$103
  • AstraZeneca$87
  • Lundbeck LLC$81
  • Vanda Pharmaceuticals Inc.$80
  • plus $85 from 5 others

What the payments were for

  • Food & beverage$823100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$823 in reported general payments places this provider in the 65th percentile of 3,007 family providers in Mississippi.

See all family providers in Mississippi

Medicare billing

Part B allowed, 2024
$22,763
Medicare patients
65
Services billed
1,046

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
FarxigaDapagliflozin Propanediol72$45,600
JardianceEmpagliflozin61$35,018
MounjaroTirzepatide22$23,759
RexultiBrexpiprazole13$18,432
OzempicSemaglutide16$17,018
Breztri AerosphereBudesonide/Glycopyr/Formoterol16$12,619
EntrestoSacubitril/Valsartan14$11,920
RybelsusSemaglutide11$10,434
TradjentaLinagliptin13$8,990
EliquisApixaban13$5,729
DapagliflozinDapagliflozin Propanediol12$5,602
JanumetSitagliptin Phos/Metformin Hcl16$5,408
SymbicortBudesonide/Formoterol Fumarate16$4,344
Lantus SolostarInsulin Glargine,hum.Rec.Anlog26$3,963
Albuterol Sulfate HfaAlbuterol Sulfate81$2,747

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AstraZenecaFarxiga, Breztri Aerosphere, Symbicort$87$62,563104 claims
Boehringer IngelheimJardiance, Tradjenta$110$44,00874 claims
Novo NordiskOzempic, Rybelsus$277$27,45227 claims
Lilly USA, LLCMounjaro$16$23,75922 claims
Otsuka America Pharmaceutical, Inc.Rexulti$37$18,43213 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 3,007 family providers in Mississippi.

Other family in Holly Springs

See the full list for Mississippi

Where these figures come from

Is this you, or does something look wrong? →